213 related articles for article (PubMed ID: 32431094)
21. [After Covid-19: Towards a new dermatology?].
Petit A; Martin L; Penso-Assathiany D; Consoli S; Assouly P; Velter C; Hefez L; Debarre JM; Haddad L;
Ann Dermatol Venereol; 2020; 147(6-7):411-412. PubMed ID: 32418776
[No Abstract] [Full Text] [Related]
22. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.
Nassim D; Jfri A; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2020; 24(4):420-421. PubMed ID: 32449619
[No Abstract] [Full Text] [Related]
23. Virtual conferences of dermatology during the COVID-19 pandemic.
Goldust M; Shivakumar S; Kroumpouzos G; Murrell DF; Rudnicka L; Jafferany M; Navarini AA
Dermatol Ther; 2020 Jul; 33(4):e13774. PubMed ID: 32506609
[No Abstract] [Full Text] [Related]
24. The effect of the "stay-at-home" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak.
Kutlu Ö; Güneş R; Coerdt K; Metin A; Khachemoune A
Dermatol Ther; 2020 Jul; 33(4):e13581. PubMed ID: 32401401
[TBL] [Abstract][Full Text] [Related]
25. A dermatologist's perspective of the COVID-19 outbreak.
Murrell DF; Arora G; Rudnicka L; Kassir M; Lotti T; Goldust M
Dermatol Ther; 2020 Jul; 33(4):e13538. PubMed ID: 32385938
[No Abstract] [Full Text] [Related]
26. Coronavirus and dermatology: a resident's perspective.
Greenberg SA
Cutis; 2020 Mar; 105(3):E22-E23. PubMed ID: 32352445
[No Abstract] [Full Text] [Related]
27. COVID-19: Challenges and opportunities for dermatology response.
Chawla S
J Dermatolog Treat; 2020 Jun; 31(4):326. PubMed ID: 32241193
[No Abstract] [Full Text] [Related]
28. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?
Megna M; Fabbrocini G; Marasca C
Int J Dermatol; 2020 Sep; 59(9):1144-1145. PubMed ID: 32710548
[No Abstract] [Full Text] [Related]
29. Teledermatology during COVID-19 pandemic: Ethical and legal considerations about the principles of treatment prescription and privacy.
Elmas ÖF; Demirbaş A; Atasoy M; Türsen Ü; Lotti T
Dermatol Ther; 2020 Jul; 33(4):e13781. PubMed ID: 32506548
[No Abstract] [Full Text] [Related]
30. How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic.
Radi G; Simonetti O; Diotallevi F; Campanati A; Brisigotti V; Molinelli E; Offidani A
Dermatol Ther; 2020 Jul; 33(4):e13740. PubMed ID: 32478970
[No Abstract] [Full Text] [Related]
31. Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them?
Cengiz FP; Emiroglu N; Bahali AG; Dizman D; Taslidere N; Akarslan TC; Gunes B; Mert O; Kucuk OS; Onsun N
Dermatol Ther; 2020 Jul; 33(4):e13470. PubMed ID: 32347618
[TBL] [Abstract][Full Text] [Related]
32. Virtual dermatopathology: A potential educational tool during COVID-19 pandemic.
Khullar G; Chandra M
Dermatol Ther; 2020 Jul; 33(4):e13755. PubMed ID: 32495961
[No Abstract] [Full Text] [Related]
33. Analysis of availability, types, and implementation of teledermatology services during COVID-19.
Gorrepati PL; Smith GP
J Am Acad Dermatol; 2020 Sep; 83(3):958-959. PubMed ID: 32531304
[No Abstract] [Full Text] [Related]
34. The ethics of charging patients an infection control fee in the context of COVID-19.
Muzumdar S; Grant-Kels JM; Feng H
J Am Acad Dermatol; 2020 Sep; 83(3):981-982. PubMed ID: 32561374
[No Abstract] [Full Text] [Related]
35. [What can we learn from the COVID-19 pandemic in general and about ourselves as dermatologists?].
Kluger N
Ann Dermatol Venereol; 2020; 147(6-7):413-417. PubMed ID: 32414508
[No Abstract] [Full Text] [Related]
36. IBD in the COVID-19 era: the value of international collaboration.
Brenner EJ; Ungaro RC; Colombel JF; Kappelman MD
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):887-888. PubMed ID: 32941833
[No Abstract] [Full Text] [Related]
37. Will teledermatology be the silver lining during and after COVID-19?
Sharma A; Jindal V; Singla P; Goldust M; Mhatre M
Dermatol Ther; 2020 Jul; 33(4):e13643. PubMed ID: 32441373
[TBL] [Abstract][Full Text] [Related]
38. Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto.
Georgakopoulos JR; Yeung J
J Cutan Med Surg; 2020; 24(4):424-425. PubMed ID: 32475151
[No Abstract] [Full Text] [Related]
39. Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID-19 emergency.
Morrone A; Cristaudo A; Ardigò M; Frascione P; Pacifico A; Giuliani M
Int J Dermatol; 2020 Jul; 59(7):e237-e238. PubMed ID: 32378200
[No Abstract] [Full Text] [Related]
40. A novel clinical set-up for examining healthy dermatology outpatients during the COVID-19 pandemic.
Gupta S; Jangra RS; Gujrathi AV; Mahendra A; Singla R; Sharma A; Gupta S
Clin Exp Dermatol; 2020 Aug; 45(6):749-750. PubMed ID: 32304576
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
